CASI Pharmaceuticals, Inc (DE)

CIK 895051 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CASI Pharmaceuticals, Inc (DE).

Recent SEC filings

FiledFormAccession number
Feb 20, 2024SC 13D/A0000950103-24-002384
Apr 26, 202320-F0001558370-23-006754
Mar 24, 2023EFFECT9999999995-23-000652
Mar 22, 202315-12G0001104659-23-035268
Mar 21, 2023S-8 POS0001104659-23-035144
Mar 21, 2023S-8 POS0001104659-23-035132
Mar 21, 2023S-8 POS0001104659-23-035140
Mar 21, 20238-K0001104659-23-035108
Mar 21, 2023POS AM0001104659-23-035121
Mar 21, 2023S-8 POS0001104659-23-035137
Feb 21, 2023SC 13D/A0000950103-23-002616
Feb 14, 2023DEF 14A0001104659-23-020539
Feb 9, 2023SC 13G/A0001623632-23-000271
Feb 1, 2023SC 13G/A0001623632-23-000216
Jan 31, 20238-K0001104659-23-008576
Nov 14, 20228-K0001104659-22-118471
Nov 14, 202210-Q0001558370-22-017615
Sep 23, 20228-K0001104659-22-102663
Sep 9, 202240001104659-22-098893
Sep 8, 202240000899243-22-030690
Sep 2, 202240000899243-22-030336
Aug 26, 202240000899243-22-029897
Aug 23, 202240000899243-22-029564
Aug 12, 20228-K0001104659-22-090027
Aug 12, 202210-Q0001558370-22-013418